Mumbai (Maharashtra) [India], January 17: As India grapples with a diabetes epidemic, Fitterfly, a leading ISO-13485 certified digital therapeutics company with clinically-proven programs, releases its comprehensive report, Reimagining Diabetes Care 2024 . This study showcases the data from the Fitterfly Diabetes prime program across 2023 and the critical role digital therapies now play in empowering people to effectively manage diabetes.